SNQ (Symbol of National Quality) stands for Safety and Quality. Since 1998, it has advanced healthcare quality through scientific evidence, expert review, and continuous improvement.
SNQ aims to build Asia’s leading platform for healthcare quality and health outcomes, connecting clinical evidence, innovation, and measurable results to advance Value-Based Healthcare globally.
Grounded in clinical evidence, research, and international guidelines.
Reviewed by more than 160 multidisciplinary experts across medicine, specialty societies, quality management, and government.
Benchmarking Taiwan’s healthcare against global standards and sharing its experience with the world.
Driving evidence-based improvement in healthcare quality, value, and outcomes.
Its embryo-inspired form symbolizes life, health, and the purpose of care, while the letters E and Q represent Excellent Quality.
Its flowing form reflects continuous improvement, while yellow and green represent health, vitality, nature, and sustainability.
The National Medical Quality Award was established by the predecessor of IBMI.
The founding of the award marked the beginning of a new era of evidence-based and professionally reviewed healthcare quality in Taiwan.
The SNQ Certification System was established, expanding quality recognition from healthcare services to biotechnology and health industries.
The award was renamed the National Biotechnology and Medicine Care Quality Award.
Performed Asia’s first liver transplant and pioneered living-donor liver transplantation with minimal blood loss, achieving world-leading case volume and survival outcomes.
SNQ continued to recognize internationally influential medical achievements across craniofacial care, microsurgery, molecular imaging, atrial fibrillation, and reconstructive medicine.
Established Asia’s first craniofacial center, with more than 30,000 cases and internationally cited cleft repair research.
Performed more than 25,000 reconstructive procedures with a 98% success rate.
Research helped reshape international guidance on oral cancer staging and nasopharyngeal cancer treatment and informed U.S. CMS coverage decisions.
Pioneered discoveries internationally recognized as the Taipei Approach and cited in leading electrophysiology textbooks.
Developed innovative intestinal-tissue techniques for vocal and vaginal reconstruction.
Trained 639 surgeons from more than 56 countries and helped establish 16 craniofacial centers across Asia.
SNQ published TOP Medical Care in Taiwan, featuring 42 internationally competitive specialties.
SNQ expanded from professional recognition to a trusted reference for patients seeking high-quality care.
SNQ continued to recognize medical achievements with international impact.
Published landmark evidence in The Lancet supporting ECPR over conventional CPR.
Developed treatment principles that informed revisions to the global KDIGO Guideline.
Evidence from more than 6,000 cases contributed to changes in the definition of AJCC T4b oral cancer.
Identified Taiwan’s high prevalence of cardiac-type Fabry disease associated with the IVS4+919G>A variant.
Pioneered a single-urine-sample diagnostic approach later incorporated into Harrison’s Principles of Internal Medicine.
Pioneered basal ganglia gene therapy for AADC deficiency, with more than 40% of treated patients gaining the ability to walk.
Improved surgical success from 40% to 80% while reducing major complications from 8% to 2%.
SNQ launched an international hospital exchange program, connecting leading hospitals and healthcare leaders across Asia.
SNQ signed a strategic collaboration agreement with the International Consortium for Health Outcomes Measurement (ICHOM).
Combining SNQ’s review of structure, process, and outcomes with ICHOM’s focus on PROMs supports a more comprehensive, outcome-driven evaluation framework.
SNQ is bringing nearly three decades of quality indicators, clinical outcomes, and international standards into the SNQ International Clinical Evidence Platform.
Making Taiwan’s healthcare outcomes visible in a language the world understands.
From quality recognition to evidence.
From national excellence to global standards.
SNQ will continue to connect quality standards, clinical evidence, health outcomes, and international collaboration to build a leading healthcare quality and outcomes platform in Asia.
Making Taiwan’s excellencevisible, measurable, and trustedworldwide.
